Altogether, these results demonstrate that patient-derived melanoma populations cultured in EGF(+)bFGF(+) medium may markedly differ in expression of MITF and MITF-dependent genes, but also in regard to the baseline pro-survival machinery. The gene discussed is FGF2; the disease is melanoma.